This communication aims to discuss the challenges and strategies in integrating guideline-directed medical therapy for heart failure with reduced ejection fraction into real-world clinical practices.
Analysis of current practices in heart failure clinics.
Discussion of barriers to GDMT optimisation.
Recommendations for enhancing implementation in real-world settings.
Identified significant gaps between clinical guidelines and actual practice.
Proposed solutions for bridging these gaps to enhance patient outcomes.